Cleerly Stock

cleerlyhealth.comHealthcare / Digital HealthFounded: 2016Funding to Date: $286.4MM

Cleerly, founded in 2016, is a digital healthcare company using AI to create a new standard of care for heart disease. The Cleerly platform is aiming to differentiate itself by using AI to measure plaque build-up in the heart’s arteries versus using indirect markers, like risk factors and symptoms of disease to help clinicians identify and define heart disease earlier and provide personalized treatment plans to patients.

Register for Details

For more details on financing and valuation for Cleerly, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Cleerly.

Register Today

Team

Management Team

James Min MD
Founder, Chief Executive Officer, President & Board Member
Krissy Wright
Chief Financial Officer
Joseph Jasser MD
Chief Operating Officer
Kimberly McCombs
Chief Strategy Officer
Nick Nieslanik
Chief Technology Officer
Zach Hong
Chief Compliance Officer & General Counsel
Jim Hartman
Chief Revenue Officer
Udo Hoffmann MD
Chief Scientfic Officer
James Earls MD
Chief Medical Officer
Kristin Binns
Chief Marketing & Communications Officer

Board Members

Glenn Steele Ph.D
LRVHealth
Justin Klein MD
Vensana Capital
Tripp Peake III
LRVHealth
Vijay Lathi
New Leaf Venture

Other companies like Cleerly in the Digital Health sector

Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$3.66B
Sector
Last Round Est. Valuation
$2B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.13B
Sector
Last Round Est. Valuation
$2.62B
Sector
Last Round Est. Valuation
$6.2B

News Highlights

How AI is detecting heart attack risk and aiming to outsmart America’s No. 1 killer
Cardiologist James Min, former professor at Weill Cornell Medical College and director of the Dalio Institute of Cardiovascular Imaging at New York-Presbyterian, founded Cleerly to find a better way to assess heart health, by applying AI to the problem, cutting down on the time it takes to flag issues and ultimately reach his goal of a “heart-attack free” world.
Cleerly raises nearly $200 mln in fundraise led by T. Rowe Price, Fidelity
Cleerly, a New York-based health tech startup, has raised $192 million in a funding round led by investment firms T. Rowe Price (TROW.O) and Fidelity Management & Research Company LLC.
Updated on: Sep 27, 2023